RankingsPricing
  1. US-listed companies
  2. PTC THERAPEUTICS, INC.
  3. Financials
  4. Capital expenditures

PTC THERAPEUTICS, INC.PTCT

Market cap
$5.9B
P/E ratio
SummaryFinancials
Period EndCapital expenditures (Million USD)YoY (%)
Dec 31, 2024-7-77.14%
Dec 31, 2023-28-11.18%
Dec 31, 2022-32+13.48%
Dec 31, 2021-28+58.12%
Dec 31, 2020-18+29.70%
Dec 31, 2019-14+93.84%
Dec 31, 2018-7+128.86%
Dec 31, 2017-3+74.61%
Dec 31, 2016-2-34.71%
Dec 31, 2015-3-41.68%
Dec 31, 2014-5+451.47%
Dec 31, 2013-1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)